Friday, Aug 29, 2008 5:00 AM

Givat Shmuel, Israel – August 29, 2008 – a new version of CimatronE, the leading CAD/CAM solution for tool making and manufacturing, will be previewed at the 2008 International Manufacturing Technology Show (IMTS), which will take place September 8-13 in Chicago, Illinois.

Helping tool makers and manufacturers deliver higher quality tools and products at lower costs and shorter cycle times, the CimatronE CAD/CAM solution suite addresses the entire process from quoting through design, engineering changes, NC, and EDM programming to delivery.
Highlights of the new and enhanced capabilities in CimatronE 9.0 include:

  • A new application for transfer die design
  • A new die quote generator
  • Greater mold design automation
  • A new application for defining electrode measuring points and probe path
  • New machining strategies for High Speed Machining (HSM) and 5-Axis milling
  • New capabilities for handling Product Manufacturing Information (PMI) throughout the design and manufacturing process

"Toolmakers and manufacturers come to the IMTS looking for the latest technologies that can help them stay ahead of the competition. We are excited to share our latest enhancements to the CimatronE product line with the people attending this show," said Bill Gibbs, President of Cimatron Technologies Inc.

The CimatronE solutions will be presented at booth# D-3037 at the IMTS, which will be taking place September 8-13 at the McCormick Place in Chicago, Illinois. For information and registration, visit http://imts.com/.

See also the latest innovations for Production by visiting the GibbsCAM booth # D-3001.

About Cimatron

With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com/.

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act Of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the company's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of the future performance and involve risks and uncertainties, many of which are beyond the company's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties of the business, refer to the Company's filings with the Securities and Exchanges Commission. The company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.